Literature DB >> 35727128

Effect of caloric intake and macronutrient composition on intestinal cholesterol absorption and bile acids in patients with obesity.

Anas Mohamad Hashem1, Lizeth Cifuentes1, Gerardo Calderon1, Maria Laura Ricardo-Silgado1, Daniel Gonzalez-Izundegui1, Alejandro Campos1, Alison McRae1, Shawna Franks1, Maria Daniela Hurtado1,2, Duane Burton1, Xuan-Mai Petterson3, Ian R Lanza3,4, Michael Camilleri1, Andres Acosta1.   

Abstract

Obesity is associated with alterations in cholesterol and bile acid (BA) metabolism. However, the interaction among dietary intake, cholesterol absorption, and BA metabolism in patients with obesity remains unclear. We conducted a 4-wk nutritional intervention nonrandomized clinical trial with three different sequential diets for a week in the following order: regular diet (RD); high calorie, high-fat diet (HCHF), washout period on RD; and low-calorie, low-fat diet (LCLF). We provided participants with meal replacements during HCHF and LCLF diets. A total of 16 participants completed the study [n = 8 normal weight (NW); n = 8 with obesity (OB)]. Overall, there was a significant increase in intestinal cholesterol uptake when changing from RD to HCHF and a reduction in intestinal cholesterol uptake from HCHF to LCLF. When analyzing by BMI groups, these findings were similar in patients with NW (RD to HCHF: P < 0.007; HCHF to LCLF: P = 0.02); however, in patients with obesity, the change in intestinal cholesterol uptake was only observed when changing from RD to HCHF (P = 0.006). There was no correlation between cholesterol absorption and fecal bile acids or other markers of BA metabolism in all patients or the subgroups. Dietary caloric content had a significant effect on cholesterol absorption, however, this effect is blunted in patients with obesity. These data are consistent with the impaired effect of a low-fat diet on cholesterol absorption in obesity.NEW & NOTEWORTHY We show how switching from a regular diet to an HCHF increases cholesterol absorption in patients with normal weight and obesity. The decrease in cholesterol absorption from an HCHF to an LCLF, on the other hand, was only seen in normal-weight controls, underlining the importance of body weight in this regulation. In addition, changes in caloric and fat content had an immediate and direct effect on hepatic bile acid production.

Entities:  

Keywords:  bile acids; caloric intake; cholesterol; fat; obesity

Mesh:

Substances:

Year:  2022        PMID: 35727128      PMCID: PMC9377780          DOI: 10.1152/ajpgi.00108.2022

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.871


  36 in total

1.  Ezetimibe (Zetia): a new type of lipid-lowering agent.

Authors:  Jigna Patel; Valerie Sheehan; Cheryle Gurk-Turner
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-07

Review 2.  Obesity: changes in lipid metabolism and the role of insulin.

Authors:  P Nestel; B Goldrick
Journal:  Clin Endocrinol Metab       Date:  1976-07

3.  Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics.

Authors:  Piia P Simonen; Helena Gylling; Tatu A Miettinen
Journal:  Obes Res       Date:  2002-05

4.  Cholesterol absorption efficiency and sterol metabolism in obesity.

Authors:  T A Miettinen; H Gylling
Journal:  Atherosclerosis       Date:  2000-11       Impact factor: 5.162

5.  Cholesterol metabolism and body composition in women: the effects of moderate weight loss.

Authors:  S Santosa; I Demonty; A H Lichtenstein; P J H Jones
Journal:  Int J Obes (Lond)       Date:  2007-01-30       Impact factor: 5.095

Review 6.  Approaches to measuring cholesterol absorption in humans.

Authors:  Nirupa R Matthan; Alice H Lichtenstein
Journal:  Atherosclerosis       Date:  2004-06       Impact factor: 5.162

7.  Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels.

Authors:  T A Miettinen; Y A Kesäniemi
Journal:  Am J Clin Nutr       Date:  1989-04       Impact factor: 7.045

8.  Description of analytical method and clinical utility of measuring serum 7-alpha-hydroxy-4-cholesten-3-one (7aC4) by mass spectrometry.

Authors:  Leslie J Donato; Alan Lueke; Stacy M Kenyon; Jeffrey W Meeusen; Michael Camilleri
Journal:  Clin Biochem       Date:  2017-10-16       Impact factor: 3.281

9.  Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans.

Authors:  T Wu; M J Bound; S D Standfield; B Gedulin; K L Jones; M Horowitz; C K Rayner
Journal:  Diabetes Obes Metab       Date:  2012-12-17       Impact factor: 6.577

10.  Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes.

Authors:  Gerardo Calderon; Alison McRae; Juraj Rievaj; Judith Davis; Inuk Zandvakili; Sara Linker-Nord; Duane Burton; Geoffrey Roberts; Frank Reimann; Bronislava Gedulin; Adrian Vella; Nicholas F LaRusso; Michael Camilleri; Fiona M Gribble; Andres Acosta
Journal:  EBioMedicine       Date:  2020-04-25       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.